NORCROSS, Ga., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will hold a conference call with debt investors on Wednesday, October 31, 2012 ET to discuss its fiscal 2013 first quarter results.
Interested debt investors and analysts should contact Immucor Investor Relations at email@example.com or 770-441-2051 for details.
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.
CONTACT: Michele Howard 770-441-2051Source:Immucor, Inc.